Laddar...
Insulin Resistance and Neurodegeneration: Progress Towards the Development of New Therapeutics for Alzheimer’s Disease
Alzheimer’s disease (AD) should be regarded as a degenerative metabolic disease caused by brain insulin resistance and deficiency, and overlapping with the molecular, biochemical, pathophysiological, and metabolic dysfunctions occurring in diabetes mellitus, non-alcoholic fatty liver disease, and me...
Sparad:
| I publikationen: | Drugs |
|---|---|
| Huvudupphovsman: | |
| Materialtyp: | Artigo |
| Språk: | Inglês |
| Publicerad: |
2017
|
| Ämnen: | |
| Länkar: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5575843/ https://ncbi.nlm.nih.gov/pubmed/27988872 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40265-016-0674-0 |
| Taggar: |
Lägg till en tagg
Inga taggar, Lägg till första taggen!
|